Office of the Associate Director (OAD)

DTP provides resources and services to both public and private research communities, maintains a robust infrastructure for anti-cancer drug discovery and development, and manages a large portfolio of grants pertinent to drug discovery and biochemical pharmacology. Upon request, DTP also provides advice on drug development issues regarding chemistry, manufacturing & control, pharmacology & toxicology, and IND requirements.

DTP/OAD provides planning, implementation, coordination and oversight for all DTP activities.

OAD Staff:

Name	Position	Email
Dr. Rose Aurigemma	Associate Director	aurigemr@mail.nih.gov
Dr. Christophe Marchand	Deputy Associate Director	marchanc@mail.nih.gov
Dr. Sharad Verma	Special Assistant to the Associate Director	sharad.verma@nih.gov
Mike Currens	Special Volunteer	currens@mail.nih.gov
Ashley Fredlock	Scientific Program Specialist	ashley.fredlock@nih.gov
Jurea Jefferies	Program Specialist	jurea.jefferies@nih.gov

About the Associate Director

Rosemarie Aurigemma, Ph.D., has been a programmatic leader in drug development for over 20 years. Her tenure as the Deputy Associate Director of DTP resulted in the launch of the Stepping Stones preclinical development program as well as the initiation and expansion of biopharmaceutical manufacturing support for adoptive cell therapies. She served as Acting Associate Director of the DCTD Developmental Therapeutics Program beginning in January 2021 until her permanent appointment in September 2021. As Associate Director, she will be managing the oversight and coordination of the programmatic, financial, and administrative functions for DTP's ten active branches. More…